Venture capital investor says selling shares in early-stage private companies via an auction process can be ‘problematic’.
New Zealand's ‘go hard, go early’ claim questioned by Fisher & Paykel Healthcare CEO.
Parties decline to comment on existence of further takeover talks.
But geo-political uncertainty makes company wary of forecasts.
Days after it ruled out a scheme of arrangement, another offer arrives.
Medical screening device maker’s sales head south due to effects of Covid in China.
The company’s new $330m profit guidance is on the basis Covid hospitalisations spike mid-year.
Collins was given great responsibility but never access to Key’s ‘inner sanctum’.
Survey respondents said a strong ethical code was the most important trait.
The NZX listed property fund manager's tourism assets were hit hard by Covid-19.